Invention Grant
- Patent Title: CLEC14A inhibitors
- Patent Title (中): CLEC14A抑制剂
-
Application No.: US13393921Application Date: 2010-09-03
-
Publication No.: US09255148B2Publication Date: 2016-02-09
- Inventor: Roy Bicknell , Xiaodong Zhuang , Manuela Mura
- Applicant: Roy Bicknell , Xiaodong Zhuang , Manuela Mura
- Applicant Address: GB London
- Assignee: Cancer Research Technology Limited
- Current Assignee: Cancer Research Technology Limited
- Current Assignee Address: GB London
- Agency: Wolf, Greenfield & Sacks, P.C.
- International Application: PCT/GB2010/001689 WO 20100903
- International Announcement: WO2011/027132 WO 20110310
- Main IPC: A61K35/00
- IPC: A61K35/00 ; A61K39/395 ; C07K16/28 ; A61K39/00
Abstract:
A method of inhibiting tumor angiogenesis in an individual, the method comprising administering to the individual an inhibitor of CLEC14A. The inhibitor may be an antibody, an siRNA molecule, an antisense molecule, or a ribozyme.
Public/Granted literature
- US20120276000A1 CLEC14A INHIBITORS Public/Granted day:2012-11-01
Information query
